Objective assessment of motor fatigue in multiple sclerosis using kinematic gait analysis: A pilot study

Journal of NeuroEngineering and Rehabilitation

Volumn 8, Issue 1, 2011, Pages

  Sehle, Aida ^a   Mündermann, Annegret ^a,b   Starrost, Klaus ^c   Sailer, Simon ^c   Becher, Inna ^a   Dettmers, Christian ^d   Vieten, Manfred ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c Kliniken Schmieder Allensbach   (Germany)

^d Kliniken Schmieder Konstanz   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOMECHANICS; COGNITION; EXERCISE; EXERCISE TEST; FEMALE; GAIT; HISTOLOGY; HUMAN; KNEE; LEG; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE FATIGUE; PATHOPHYSIOLOGY; PHYSIOLOGY; PILOT STUDY; QUESTIONNAIRE; STATISTICAL ANALYSIS; VIDEORECORDING;

ADULT; BIOMECHANICS; COGNITION; DATA INTERPRETATION, STATISTICAL; EXERCISE TEST; FEMALE; GAIT; HUMANS; KNEE; LOWER EXTREMITY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE FATIGUE; PHYSICAL EXERTION; PILOT PROJECTS; QUESTIONNAIRES; VIDEO RECORDING;

EID: 82955192567     PISSN: None     EISSN: 17430003     Source Type: Journal    
DOI: 10.1186/1743-0003-8-59     Document Type: Article

References (48)

1. Estimated prevalence of multiple sklerosis in Germany [Hochrechnung der Zahl an Multiple Sclerosis erkrankten Patienten in Deutschland]. Hein T, Hopfenmuüller W, Nervenarzt 2000 71 288 294 10.1007/s001150050559 10795096 (Pubitemid 30210324)
2. The changing demographic pattern of multiple sclerosis epidemiology. Koch-Henriksen N, Sorensen PS, Lancet Neurology 2010 9 5 520 532 10.1016/S1474-4422(10)70064-8 20398859
3. Multiple Sclerosis Overview. Stüve O, Oksenberg J, GeneReviews [Internet] Seattle: University of Washington, Pagon RA, Bird TC, Dolan CR, 2006
4. Fatigue in multiple sclerosis. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC, Archives of Neurology 1988 45 4 435 437 3355400 (Pubitemid 18098285)
5. The impact of fatigue on patients with multiple sclerosis. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ, Canadian Journal of Neurological Sciences 1994 21 1 9 14 8180914 (Pubitemid 24090744)
6. Neuroimmune and neuropsychiatric aspects of chronic fatigue syndrome. Krupp LB, Pollina D, Advances in Neuroimmunology 1996 6 2 155 167 10.1016/0960-5428(96)00014-9 8876771 (Pubitemid 26279974)
7. Fatigue. Barnett R, Lancet 2005 366 9479 21 15993215
8. Origin of fatigue in multiple sclerosis: review of the literature. Kos D, Kerckhofs E, Nagels G, D'Hooghe M B, Ilsbroukx S, Neurorehabilitation and Neural Repair 2008 22 1 91 100 17409388 (Pubitemid 350223141)
9. Fatigue in multiple sclerosis. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC, Archives of neurology 1988 45 4 435 437 3355400 (Pubitemid 18098285)
10. The effects of experimental demyelination on conduction in the central nervous system. McDonald WI, Sears TA, Brain 1970 93 3 583 598 10.1093/brain/93.3.583 4319185
11. Activity-dependent hyperpolarization of human motor axons produced by natural activity. Vagg R, Mogyoros I, Kiernan MC, Burke D, Journal of Physiology 1998 507 Pt 3 919 925 9508850 (Pubitemid 28143590)
12. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. Bolanos JP, Almeida A, Stewart V, Peuchen S, Land JM, Clark JB, Heales SJ, Journal of Neurochemistry 1997 68 6 2227 2240 9166714 (Pubitemid 27218141)
13. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Redford EJ, Kapoor R, Smith KJ, Brain 1997 120 Pt 12 2149 2157 9448570 (Pubitemid 28014591)
14. Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement - EEG evidence. Leocani L, Colombo B, Magnani G, Martinelli-Boneschi F, Cursi M, Rossi P, Martinelli V, Comi G, Neuroimage 2001 13 6 Pt 1 1186 1192 11352624 (Pubitemid 32553549)
15. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Filippi M, Rocca MA, Colombo B, Falini A, Codella M, Scotti G, Comi G, Neuroimage 2002 15 3 559 567 10.1006/nimg.2001.1011 11848698 (Pubitemid 34852523)
16. Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. Tedeschi G, Dinacci D, Lavorgna L, Prinster A, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Servillo G, et al. Journal of Neurological Sciences 2007 263 1-2 15 19 10.1016/j.jns.2007.07.004 (Pubitemid 350029853)
17. Comparison of the influence of different rehabilitation programmes on clinical, spirometric and spiroergometric parameters in patients with multiple sclerosis. Rasova K, Havrdova E, Brandejsky P, Zalisova M, Foubikova B, Martinkova P, Multiple Sclerosis 2006 12 2 227 234 10.1191/135248506ms1248oa 16629428
18. Effects of a 6-month exercise program on patients with multiple sclerosis: a randomized study. Romberg A, Virtanen A, Ruutiainen J, Aunola S, Karppi SL, Vaara M, Surakka J, Pohjolainen T, Seppanen A, Neurology 2004 63 11 2034 2038 15596746 (Pubitemid 39636248)
19. Effects of aerobic and strength exercise on motor fatigue in men and women with multiple sclerosis: a randomized controlled trial. Surakka J, Romberg A, Ruutiainen J, Aunola S, Virtanen A, Karppi SL, Maentaka K, Clinical Rehabilitation 2004 18 7 737 746 10.1191/0269215504cr780oa 15573829 (Pubitemid 39545192)
20. Cooling garment treatment in MS: clinical improvement and decrease in leukocyte NO production. Beenakker EA, Oparina TI, Hartgring A, Teelken A, Arutjunyan AV, De Keyser J, Neurology 2001 57 5 892 894 11552024 (Pubitemid 32845515)
21. A randomized controlled study of the acute and chronic effects of cooling therapy for MS. Schwid SR, Petrie MD, Murray R, Leitch J, Bowen J, Alquist A, Pelligrino R, Roberts A, Harper-Bennie J, Milan MD, et al. Neurology 2003 60 12 1955 1960 12821739 (Pubitemid 36736012)
22. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR, Lancet 2009 373 9665 732 738 10.1016/S0140-6736(09)60442-6 19249634
23. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial. Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A, Fieschi C, Journal of Neurological Sciences 2004 218 1-2 103 108 10.1016/j.jns.2003.11.005 (Pubitemid 38169402)
24. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Krupp LB, Coyle PK, Doscher C, Miller A, Cross AH, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R, Neurology 1995 45 11 1956 1961 7501140
25. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD, Archives of Neurology 1989 46 10 1121 1123 2803071 (Pubitemid 19246303)
26. Test-retest reliability and convergent validity of the Fatigue Impact Scale for persons with multiple sclerosis. Mathiowetz V, American Journal of Occupational Therapy 2003 57 4 389 395 10.5014/ajot.57.4.389 12911080 (Pubitemid 39256379)
27. The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis. Iriarte J, Katsamakis G, de Castro P, Multiple Sclerosis 1999 5 1 10 16 10096097 (Pubitemid 29092445)
28. A rapid screening tool for fatigue impact in multiple sclerosis. Kos D, Nagels G, D'Hooghe MB, Duportail M, Kerckhofs E, BMC Neurology 2006 6 27 10.1186/1471-2377-6-27 16916440 (Pubitemid 44488789)
29. Reliability and validity of the Swedish version of the Fatigue Impact Scale (FIS). Flensner G, Ek AC, Soderhamn O, Scandinavian Journal of Occupational Therapy 2005 12 4 170 180 10.1080/11038120510031806 16457090 (Pubitemid 43078122)
30. Novel method for measurement of fatigue in multiple sclerosis: Real-Time Digital Fatigue Score. Kim E, Lovera J, Schaben L, Melara J, Bourdette D, Whitham R, Journal of Rehabilitation Research and Development 2010 47 5 477 484 10.1682/JRRD.2009.09.0151 20803391
31. The characterisation of gait patterns of people with multiple sclerosis. Kelleher KJ, Spence W, Solomonidis S, Apatsidis D, Disability and Rehabilitation 2010 32 15 1242 1250 10.3109/09638280903464497 20156050
32. Endurance exercise improves walking distance in MS patients with fatigue. Dettmers C, Sulzmann M, Ruchay-Plossl A, Gutler R, Vieten M, Acta Neurologica Scandinavica 2009 120 4 251 257 10.1111/j.1600-0404.2008.01152.x 19178385
33. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Penner IK, Raselli C, Stocklin M, Opwis K, Kappos L, Calabrese P, Multiple Sclerosis 2009 15 12 1509 1517 10.1177/1352458509348519 19995840
34. Fatigue and Multiple Sclerosis: evidence based management strategies for fatigue in multiple sclerosis. Guidelines MSCfCP, Multiple Sclerosis Council for Clinical Practice Guidelines 1998
35. Grip force control in individuals with multiple sclerosis. Iyengar V, Santos MJ, Ko M, Aruin AS, Neurorehabilitation and neural repair 2009 23 8 855 861 10.1177/1545968309338194 19531607
36. Effects of muscle fatigue on gait characteristics under single and dual-task conditions in young and older adults. Granacher U, Wolf I, Wehrle A, Bridenbaugh S, Kressig RW, J Neuroeng Rehabil 2010 7 56 10.1186/1743-0003-7-56 21062458
37. Fatigued patients with multiple sclerosis have impaired central muscle activation. Andreasen AK, Jakobsen J, Petersen T, Andersen H, Multiple Sclerosis 2009 15 7 818 827 10.1177/1352458509105383 19465444
38. Functional magnetic resonance imaging and multiple sclerosis: the evidence for neuronal plasticity. Buckle GJ, Journal of Neuroimaging 2005 15 4 Suppl 82S 93S 16385021 (Pubitemid 43010534)
39. Brain reorganization during attention and memory tasks in multiple sclerosis: insights from functional MRI studies. Mainero C, Pantano P, Caramia F, Pozzilli C, J Neurol Sci 2006 245 1-2 93 98 10.1016/j.jns.2005.08.024 16626753 (Pubitemid 44218704)
40. Simple and complex movement-associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Filippi M, Rocca MA, Mezzapesa DM, Ghezzi A, Falini A, Martinelli V, Scotti G, Comi G, Hum Brain Mapp 2004 21 2 108 117 10.1002/hbm.10160 14755598 (Pubitemid 38167035)
41. Cortical motor reorganization after a single clinical attack of multiple sclerosis. Pantano P, Iannetti GD, Caramia F, Mainero C, Di Legge S, Bozzao L, Pozzilli C, Lenzi GL, Brain 2002 125 Pt 7 1607 1615 12077009 (Pubitemid 34755174)
42. Correlations between structural CNS damage and functional MRI changes in primary progressive MS. Filippi M, Rocca MA, Falini A, Caputo D, Ghezzi A, Colombo B, Scotti G, Comi G, Neuroimage 2002 15 3 537 546 10.1006/nimg.2001.1023 11848696 (Pubitemid 34852521)
43. Structural and functional MRI correlates of Stroop control in benign MS. Rocca MA, Valsasina P, Ceccarelli A, Absinta M, Ghezzi A, Riccitelli G, Pagani E, Falini A, Comi G, Scotti G, et al. Hum Brain Mapp 2009 30 1 276 290 10.1002/hbm.20504 18041737
44. Therapy-induced plasticity of cognitive functions in MS patients: insights from fMRI. Penner IK, Kappos L, Rausch M, Opwis K, Radu EW, J Physiol Paris 2006 99 4-6 455 462 10.1016/j.jphysparis.2006.03.008 16713204 (Pubitemid 43850802)
45. Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis. Penner IK, Opwis K, Kappos L, J Neurol 2007 254 Suppl 2 I53 57 17503130
46. Enhanced corticomotor excitability with dynamic fatiguing exercise of the lower limb in multiple sclerosis. Thickbroom GW, Sacco P, Faulkner DL, Kermode AG, Mastaglia FL, Journal of neurology 2008 255 7 1001 1005 10.1007/s00415-008- 0818-6 18338192
47. Does functional electrical stimulation for foot drop strengthen corticospinal connections? Everaert DG, Thompson AK, Chong SL, Stein RB, Neurorehabilitation and neural repair 2010 24 2 168 177 10.1177/1545968309349939 19861590
48. Accelerometry and its association with objective markers of walking limitations in ambulatory adults with multiple sclerosis. Motl RW, Dlugonski D, Suh Y, Weikert M, Fernhall B, Goldman M, Arch Phys Med Rehabil 2010 91 12 1942 1947 10.1016/j.apmr.2010.08.011 21112438